Kraj: Izrael
Język: hebrajski
Źródło: Ministry of Health
TEMOPORFIN 4 MG/ML
EINAT MEDICAL AGENCIES (1997) LTD
L01XD05
SOLUTION FOR INJECTION
I.V
BIOLITEC PHARMA LTD., UK
TEMOPORFIN
Foscan is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.
2008-12-01